Taken together, the analysis of RNA-Seq data coupled with results from our in vivo experimental CRC models indicated that STAT2 confers increased susceptibility to CRC in various settings relying on distinct mechanisms, i.e., inflammation-dependent (AOM–DSS) and inflammation-independent (ApcMin/+). The gene discussed is STAT2; the disease is colorectal carcinoma.